Research on Approaches for Regulation of the “Off-label” use of Medicinal Products in the European Union
Despite the increasingly strict legislation on medicinal products, the „off-label use“ or „use of medicinal product outside the approved summary of product characteristics (SmPC)“ is a weak point of today’s drug regulation and raises many questions about the risk, ethics, and legality of this type o...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Sciendo
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b42bba9c6cf34f679dee54c7a912cad4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|